Segment Information - Summary of Summarized Financial Information for the Company's Segments (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information
Consolidated revenue	$ 76,192,000	$ 55,161,000
Total segment depreciation expense	541,000	314,000
Total segment amortization	728,000	673,000
Goodwill impairment charges	16,867,000	0
Selling, general and administrative expense	28,830,000	29,806,000
Non-segment depreciation and amortization	1,269,000	987,000
Loss from operations	(32,867,000)	(18,471,000)
Operating segments
Segment Reporting Information
Consolidated revenue	76,192,000	55,161,000
Total segment direct costs	62,093,000	42,839,000
Total segment depreciation expense	422,000	297,000
Total segment amortization	727,000	674,000
Total segment operating income	12,950,000	11,351,000
Goodwill impairment charges	16,867,000	0
Selling, general and administrative expense	28,830,000	29,806,000
Non-segment assets
Segment Reporting Information
Non-segment depreciation and amortization	120,000	16,000
Patient services | Operating segments
Segment Reporting Information
Consolidated revenue	50,273,000	35,057,000
Total segment direct costs	42,814,000	27,378,000
Total segment depreciation expense	406,000	250,000
Total segment amortization	675,000	621,000
Total segment operating income	6,378,000	6,808,000
Goodwill impairment charges	16,235,000	0
Dispensary | Operating segments
Segment Reporting Information
Consolidated revenue	24,240,000	18,679,000
Total segment direct costs	19,145,000	15,324,000
Total segment depreciation expense	16,000	0
Total segment amortization	0	0
Total segment operating income	5,079,000	3,355,000
Goodwill impairment charges	0	0
Clinical trials & other | Operating segments
Segment Reporting Information
Consolidated revenue	1,679,000	1,425,000
Total segment direct costs	134,000	137,000
Total segment depreciation expense	0	47,000
Total segment amortization	52,000	53,000
Total segment operating income	1,493,000	1,188,000
Goodwill impairment charges	$ 632,000	$ 0